Schedule 13D ownership disclosure
Genesis Biopharma, Inc
Security class unavailable · CUSIP: 37182R102
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,868,074
- Percent of class
- 13.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019687-15-000536
- Form type
- SC 13D
- Filer
- BRISTOL INVESTMENT FUND LTD
- CIK
- CIK 1174866
- Filed
- Feb 11, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13D beneficial ownership